Sales and Marketing

Showing 15 posts of 11520 posts found.

Schering’s new low-dose contraceptive approved in Netherlands

August 19, 2005 Sales and Marketing

Yasminelle, a new low-dose oral contraceptive from Schering has received its first European marketing approval in the Netherlands. The country …

Global giant VNU acquires IMS Health for $7 billion

August 17, 2005 Sales and Marketing

Dutch media, consumer and marketing information group VNU has bought IMS Health for $7 billion, as it looks to expand …

FDA approves Diovan for cardiovascular indication

August 16, 2005 Sales and Marketing

Novartis' biggest selling drug Diovan has received US approval for a new indication, as it strives to bolster its position …

Celebrex approved for new arthritis indication

August 8, 2005 Sales and Marketing

Celebrex has received US approval for a new indication as Pfizer looks to revive tumbling sales of its flagship COX- …

Teva’s modest sales growth driven by MS treatment

August 4, 2005 Sales and Marketing

Teva Pharmaceuticals, the world's number one generics manufacturer, has posted modest second quarter results driven by its patent-protected multiple sclerosis …

AstraZeneca name McKillop’s successor as sales rise

August 3, 2005 Sales and Marketing

Sir Tom McKillop is to step down in January as chief executive of AstraZeneca laying to rest speculation about the …

Survival of the fittest

August 1, 2005 Sales and Marketing

The title for this piece was inspired by a sort of scientific hobby I have, which revolves around critical thinking …

Schering-Plough’s new anti-fungal gains EMEA approval

July 29, 2005 Sales and Marketing

A new treatment for fungal infections has been given a positive opinion by the EMEA.Schering-Plough's Noxafil (posaconazole) is a novel …

New drug-resistant HIV treatment recommended

July 28, 2005 Sales and Marketing

Boehringer Ingelheim's new treatment for patients with drug-resistant HIV has been recommended for approval by the European regulator.The prevalence of …

New 28-day pack for Cozaar launched

July 20, 2005 Sales and Marketing

A new 28-day pack of Merck Sharp & Dohme's top-selling hypertension treatment Cozaar has been launched in the UK.The 50mg …

Arixtra approved for new blood clot indication

July 20, 2005 Sales and Marketing Arixtra, GlaxoSmithKline

GlaxoSmithKline’s Arixtra has gained approval for use in preventing blood clots in high-risk patients undergoing abdominal surgery.The drug is already …
The Gateway to Local Adoption Series

Latest content